Mohan Karkada

965 total citations
27 papers, 705 citations indexed

About

Mohan Karkada is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Mohan Karkada has authored 27 papers receiving a total of 705 indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Immunology, 11 papers in Oncology and 9 papers in Molecular Biology. Recurrent topics in Mohan Karkada's work include Immunotherapy and Immune Responses (24 papers), Chemokine receptors and signaling (6 papers) and vaccines and immunoinformatics approaches (5 papers). Mohan Karkada is often cited by papers focused on Immunotherapy and Immune Responses (24 papers), Chemokine receptors and signaling (6 papers) and vaccines and immunoinformatics approaches (5 papers). Mohan Karkada collaborates with scholars based in Canada, United States and Belgium. Mohan Karkada's co-authors include Thomas B. Issekutz, Marc Mansour, Genevieve Weir, Neil L. Berinstein, Marianne M. Stanford, Devanand M. Pinto, Jean S. Marshall, Maya Shmulevitz, Patrick W.K. Lee and Ziqiang Ding and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Mohan Karkada

27 papers receiving 694 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Mohan Karkada Canada	15	459	224	163	68	56	27	705
Chiara Buracchi Italy	14	665 1.4×	359 1.6×	248 1.5×	70 1.0×	61 1.1×	25	1.1k
L Gemmell United States	9	523 1.1×	204 0.9×	238 1.5×	94 1.4×	38 0.7×	10	995
Jorge Schettini United States	13	340 0.7×	228 1.0×	299 1.8×	71 1.0×	34 0.6×	14	686
Kim C. M. Santegoets Netherlands	15	450 1.0×	97 0.4×	249 1.5×	89 1.3×	45 0.8×	20	861
Kazuhide Tsuji Japan	17	636 1.4×	398 1.8×	181 1.1×	116 1.7×	31 0.6×	38	1.2k
Joseph D. Ferrari United States	11	548 1.2×	91 0.4×	357 2.2×	94 1.4×	100 1.8×	14	1.0k
Joke S. van de Gevel Netherlands	16	249 0.5×	191 0.9×	342 2.1×	116 1.7×	39 0.7×	26	817
Cynthia M. Fehres Netherlands	13	556 1.2×	106 0.5×	302 1.9×	73 1.1×	19 0.3×	29	750
Marcus Pericin Switzerland	11	1.0k 2.2×	423 1.9×	288 1.8×	119 1.8×	66 1.2×	13	1.3k
Michelle L. McCully Canada	11	489 1.1×	146 0.7×	95 0.6×	55 0.8×	31 0.6×	21	699

Countries citing papers authored by Mohan Karkada

Since Specialization

Citations

This map shows the geographic impact of Mohan Karkada's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohan Karkada with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohan Karkada more than expected).

Fields of papers citing papers by Mohan Karkada

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohan Karkada. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohan Karkada. The network helps show where Mohan Karkada may publish in the future.

Co-authorship network of co-authors of Mohan Karkada

This figure shows the co-authorship network connecting the top 25 collaborators of Mohan Karkada. A scholar is included among the top collaborators of Mohan Karkada based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohan Karkada. Mohan Karkada is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Weir, Genevieve, Mohan Karkada, David W. Hoskin, et al.. (2017). Combination of poly I:C and Pam3CSK4 enhances activation of B cells in vitro and boosts antibody responses to protein vaccines in vivo. PLoS ONE. 12(6). e0180073–e0180073. 25 indexed citations

Berinstein, Neil L., Matthew C. Cheung, Rena Buckstein, et al.. (2016). A phase 2 clinical trial testing DPX-Survivac and metronomic low dose cyclophosphamide as immunotherapy for patients with recurrent diffuse large b-cell lymphoma.. Journal of Clinical Oncology. 34(15_suppl). e14578–e14578. 3 indexed citations

Villella, Jeannine, Michelle Wilson, Neil L. Berinstein, et al.. (2016). Determination of optimal dose and treatment schedule of the immunotherapeutic vaccine, DPX-Survivac, for combination immunotherapy treatment of ovarian, fallopian tube or peritoneal cancer (OC): A phase Ib study.. Journal of Clinical Oncology. 34(15_suppl). e14577–e14577. 2 indexed citations

Villella, Jeannine, Michelle Wilson, Neil L. Berinstein, et al.. (2015). Safety, immunogenicity, and clinical activity of the immunotherapeutic vaccine, DPX-Survivac, in a Phase 1/1b trial of women with ovarian, fallopian tube, or peritoneal cancer.. Journal of Clinical Oncology. 33(15_suppl). 3072–3072. 3 indexed citations

Weir, Genevieve, Marianne M. Stanford, Neil L. Berinstein, et al.. (2014). Metronomic cyclophosphamide enhances HPV16E7 peptide vaccine induced antigen-specific and cytotoxic T-cell mediated antitumor immune response. OncoImmunology. 3(8). e953407–e953407. 29 indexed citations

Karkada, Mohan, Marc Mansour, & Neil L. Berinstein. (2014). Therapeutic vaccines and cancer: focus on DPX-0907. Biologics. 8. 27–27. 40 indexed citations

Brewer, Kimberly, Nicole A. Pelot, Marianne M. Stanford, et al.. (2014). Clearance of depot vaccine SPIO-labeled antigen and substrate visualized using MRI. Vaccine. 32(51). 6956–6962. 21 indexed citations

Peretz, Yoav, Dominic Gagnon, G Croteau, et al.. (2014). Abstract CT411: Immune profiling of patients vaccinated with the survivin targeted therapeutic vaccine DPX-Survivac demonstrates durable polyfunctional CD4+ and CD8+ T cells in ovarian cancer patients. Cancer Research. 74(19_Supplement). CT411–CT411. 1 indexed citations

Berinstein, Neil L., Amit M. Oza, Kunle Odunsi, et al.. (2013). Effect of oral cyclophosphamide on the immunogenicity of DPX-Survivac in ovarian cancer patients: Results of a phase I study.. Journal of Clinical Oncology. 31(15_suppl). 3030–3030. 6 indexed citations

10.

Karkada, Mohan, et al.. (2013). Tumor Inhibition by DepoVax-Based Cancer Vaccine Is Accompanied by Reduced Regulatory/Suppressor Cell Proliferation and Tumor Infiltration. ISRN Oncology. 2013. 1–13. 21 indexed citations

11.

Berinstein, Neil L., Mohan Karkada, Michael A. Morse, et al.. (2012). First-in-man application of a novel therapeutic cancer vaccine formulation with the capacity to induce multi-functional T cell responses in ovarian, breast and prostate cancer patients. Journal of Translational Medicine. 10(1). 156–156. 68 indexed citations

12.

Issekutz, Andrew C., P.J. Quinn, Bianca Lang, et al.. (2011). Coexpression of chemokine receptors CCR5, CXCR3, and CCR4 and ligands for P‐ and E‐selectin on T lymphocytes of patients with juvenile idiopathic arthritis. Arthritis & Rheumatism. 63(11). 3467–3476. 12 indexed citations

13.

Karkada, Mohan, Genevieve Weir, Lisa D. MacDonald, et al.. (2010). A Novel Breast/Ovarian Cancer Peptide Vaccine Platform That Promotes Specific Type-1 but not Treg/Tr1-type Responses. Journal of Immunotherapy. 33(3). 250–261. 27 indexed citations

14.

Karkada, Mohan, et al.. (2010). A liposome-based platform, VacciMax®, and its modified water-free platform DepoVax™ enhance efficacy of in vivo nucleic acid delivery. Vaccine. 28(38). 6176–6182. 31 indexed citations

15.

Pugazhendhi, Srinivasan, et al.. (2008). Effect of Vibrio cholerae on Chemokine Gene Expression in HT29 cells and its Modulation by Lactobacillus GG. Scandinavian Journal of Immunology. 69(3). 181–187. 17 indexed citations

16.

Karkada, Mohan & Thomas B. Issekutz. (2007). Blockade of Chemokine Receptor CXCR3 Inhibits T Cell Recruitment to Inflamed Joints and Decreases the Severity of Adjuvant Arthritis. The Journal of Immunology. 179(12). 8463–8469. 85 indexed citations

17.

Latta, Markus, Mohan Karkada, & Thomas B. Issekutz. (2007). CXCR6 is expressed on T cells in both T helper type 1 (Th1) inflammation and allergen‐induced Th2 lung inflammation but is only a weak mediator of chemotaxis. Immunology. 121(4). 555–564. 36 indexed citations

18.

Karkada, Mohan, et al.. (2005). CXCR3 is required for migration to dermal inflammation by normal andin vivo activated T cells: differential requirements by CD4 and CD8 memory subsets. European Journal of Immunology. 35(6). 1702–1711. 46 indexed citations

19.

Karkada, Mohan, Devanand M. Pinto, & Thomas B. Issekutz. (2003). Identification of Tissue Transglutaminase as a Novel Molecule Involved In Human CD8+ T Cell Transendothelial Migration. The Journal of Immunology. 171(6). 3179–3186. 50 indexed citations

20.

Karkada, Mohan, Ziqiang Ding, John G. Hanly, & Thomas B. Issekutz. (2002). IFN-γ-Inducible T Cell α Chemoattractant Is a Potent Stimulator of Normal Human Blood T Lymphocyte Transendothelial Migration: Differential Regulation by IFN-γ and TNF-α. The Journal of Immunology. 168(12). 6420–6428. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact